Browse Category

Investment Updates News 10 November 2025 - 30 November 2025

Qualcomm (QCOM) Stock Rises as Alphawave AI Deal Advances and Snapdragon 8 Gen 5 Launches — November 28, 2025

Qualcomm (QCOM) Stock Rises as Alphawave AI Deal Advances and Snapdragon 8 Gen 5 Launches — November 28, 2025

Qualcomm Incorporated (NASDAQ: QCOM) finished Friday, November 28, 2025, on a positive note, with investors digesting a flood of AI‑focused headlines ranging from its pending Alphawave IP Group acquisition to fresh mobile and data‑center chip launches and big new institutional
Capillary Technologies India Share Price Today, 27 November 2025: CAPILLARY Cools 3% After Fiery IPO Debut

Capillary Technologies India Share Price Today, 27 November 2025: CAPILLARY Cools 3% After Fiery IPO Debut

Capillary Technologies India Ltd (NSE: CAPILLARY, BSE: 544614) is seeing some profit‑booking on Thursday, 27 November 2025, after a high‑octane first week on the bourses. Around mid‑session, the SaaS company’s stock is trading in the ₹666–₹670 zone, down roughly 3–3.5%
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Today (T): Price Holds Up as Settlement Deadline Arrives and Vanguard Boosts Its Stake — November 18, 2025

AT&T stock is edging higher on Tuesday, November 18, 2025, as investors digest a major data‑breach settlement deadline, fresh institutional buying from Vanguard, and mixed Wall Street views — all against a backdrop of a global market sell‑off. Published: November
18 November 2025
Amazon Stock Skyrockets to Record High on AWS Boom – Analysts Predict More Upside

Amazon Stock Today (Nov. 11, 2025): AMZN Edges Higher as Amazon Ads Unboxed Debuts 315M‑Viewer Reach; Prime Video Adds The Game Awards & Soccer PPV

Snapshot: How AMZN Is Trading Today Amazon (NASDAQ: AMZN) was up about 0.4% at $249.30 in mid‑afternoon New York trading as of 2:36 p.m. ET. Regular U.S. stock trading hours are in effect on Veterans Day, though the U.S. bond market is closed.  MarketWatch+2Barron’s+2
Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto, Inc. (NASDAQ: GLTO) said this morning it completed the acquisition of Damora Therapeutics and closed a $284.9 million oversubscribed private placement, a one‑two punch that instantly refocuses the company on mutant calreticulin (mutCALR) therapies for myeloproliferative neoplasms (MPNs) and
Go toTop